Header Logo

Connection

HESHAM MOHAMED to Drug Substitution

Back to Details
This is a "connection" page, showing publications HESHAM MOHAMED has written about Drug Substitution.
HESHAM MOHAMED
Connection Strength
0.154
Drug Substitution
  1. Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study. Ann Hematol. 2018 Aug; 97(8):1357-1367.
    View in: PubMed
    Score: 0.154
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.